These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1960074

  • 1. Flecainide toxicity in a neonate with supraventricular tachycardia.
    Zeigler VL, Peterson J.
    Heart Lung; 1991 Nov; 20(6):689-91. PubMed ID: 1960074
    [Abstract] [Full Text] [Related]

  • 2. Flecainide acetate for the treatment of atrial and ventricular arrhythmias.
    Apostolakis S, Oeff M, Tebbe U, Fabritz L, Breithardt G, Kirchhof P.
    Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160
    [Abstract] [Full Text] [Related]

  • 3. Complete Heart Block Secondary to Flecainide Toxicity: Is It Time for CYP2D6 Genotype Testing?
    Poh BH, Lee JH, Abdul Haium AA, Choo TLJ.
    Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32561613
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 5. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM, Ward Platt MP.
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract] [Full Text] [Related]

  • 6. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F.
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 May; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 8. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 9. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 20; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 10. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 11. Flecainide acetate in the treatment of resistant supraventricular arrhythmias.
    Epstein M, Jardine RM, Obel IW.
    S Afr Med J; 1988 Dec 03; 74(11):559-62. PubMed ID: 3143159
    [Abstract] [Full Text] [Related]

  • 12. [Flecainide and anti-arrhythmia therapy].
    Croce L, Romano S, Pozzoni L, Lomuscio A.
    Minerva Med; 1988 Mar 03; 79(3):229-34. PubMed ID: 3129677
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 14. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents].
    Le Davay M, Victor J, Dupuis JM, Merheb M, Tran P, Tadeï A.
    Ann Cardiol Angeiol (Paris); 1994 May 25; 43(5):253-5. PubMed ID: 8074416
    [Abstract] [Full Text] [Related]

  • 15. [Our experience with flecainide acetate in resistant arrhythmias in children. Apropos of 35 cases].
    Denjoy I, Lucet V, Do Ngoc D, Magnier S, Casasoprana A, Coumel P.
    Arch Mal Coeur Vaiss; 1991 May 25; 84(5):647-52. PubMed ID: 1910326
    [Abstract] [Full Text] [Related]

  • 16. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA, Gillette PC, Benson DW.
    J Am Coll Cardiol; 1991 Aug 25; 18(2):356-65. PubMed ID: 1906902
    [Abstract] [Full Text] [Related]

  • 17. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M, Wiesfeld AC, van Veldhuisen DJ, van Gelder IC.
    Ned Tijdschr Geneeskd; 2006 May 06; 150(18):1027-31. PubMed ID: 16715868
    [Abstract] [Full Text] [Related]

  • 18. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul 24; 34(875):71-2. PubMed ID: 1630411
    [No Abstract] [Full Text] [Related]

  • 19. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ, Best TH, Eswaran H, Lowery CL.
    Obstet Gynecol; 2006 Sep 24; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [Abstract] [Full Text] [Related]

  • 20. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May 24; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.